Elsevier

Epilepsy Research

Volume 13, Issue 2, November 1992, Pages 129-139
Epilepsy Research

Research paper
PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy

https://doi.org/10.1016/0920-1211(92)90068-5Get rights and content

Abstract

We used [18F]cyclofoxy (CF), a potent opiate antagonist with affinity for mu and kappa receptors, and the Scanditronix PC1024-7B PET scanner to study 14 patients with complex partial seizures (CPS), and 14 normal controls. Epileptic foci were localized by prolonged EEG-video monitoring. EEG was recorded continuously during each scan. Immediately before CF administration, [15O]labeled water was used to measure cerebral blood flow, and showed hypoperfusion ipsilateral to the EEG focus. Blood samples (corrected for radiolabeled metabolites) and tissue time-activity data were acquired over 90 min following bolus CF injection. Anatomic regions were outlined directly on the PET images. A kinetic model was used to derive the total volume of distribution (Vt) in each brain region. Specific binding (Vs) was determined by subtracting non-specific binding (Vt) measured in a receptor-poor brain region (occipital cortex). Regions with high Vs included mesial temporal lobes, thalamus, basal ganglia, and frontal cortex. Individual patients appeared to have higher binding in temporal lobe ipsilateral to the EEG focus, but there was no asymmetry for the patients as a group in mean Vt or Vs i anterior mesial, posterior mesial, anterior lateral, posterior lateral temporal cortex, thalamus, basal ganglia, or, for Vt, in regions of low specific binding: occipital lobe, parietal lobe, cerebellum.

References (39)

  • R.B. Rothman et al.

    An examination of the opiate receptor subtype labelled by [3H]cyclofoxy: an opiate antagonist suitable for positron emission tomography

    Biol. Psychiatry

    (1988)
  • I. Savic et al.

    In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci

    Lancet

    (1988)
  • O. Vindrola et al.

    Amygdaloid kindling enhances the enkephalin content in the rat brain

    Neurosci. Lett.

    (1981)
  • H. Akaike

    An information criterion (AIC)

    Math. Sci.

    (1976)
  • N.M. Alpert et al.

    Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography

    J. Cerebral Blood Flow Metab.

    (1985)
  • R.G. Blasberg et al.

    Strategies for the study of the opiate receptor in brain: application to the opiate antagonist cyclofoxy

    J. Cereb. Blood Flow Metab.

    (1989)
  • T.R. Burke et al.

    Probes for narcotic receptor mediated phenomena 11. Synthesis of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5a-epoxy-6β-fluoromorphinans (foxy and cyclofoxy) as models of opioid ligands suitable for positron emission transaxial tomography

    Heterocycles

    (1985)
  • R.E. Carson et al.

    A kinetic study of the active and inactive enantiomers of [18F]cyclofoxy with PET

    J. Cereb. Blood Flow Metab.

    (1989)
  • H.T. Chugani et al.

    Opioid-induced epileptogenic phenomena: anatomical, behavioral, and electrographic features

    Ann. Neurol.

    (1984)
  • Cited by (71)

    • PET imaging in epilepsy

      2022, Nuclear Medicine and Molecular Imaging: Volume 1-4
    • Neuroimaging of epilepsy

      2016, Handbook of Clinical Neurology
    • Surgical outcome in patients with MRI-negative, PET-positive temporal lobe epilepsy

      2015, Seizure
      Citation Excerpt :

      Among cases undergoing invasive EEG monitoring, surgical outcomes of PET-positive cases are better. Invasive EEG monitoring is gold standard when there are difficulties or conflicts in noninvasive assessments [24–27]. The demonstration that excellent surgical outcomes are achieved in TLE cases, if IED and ictal EEG findings on noninvasive EEG are consistent with PET findings has led to a new understanding [15,28,29].

    • Functional imaging: PET

      2013, Handbook of Clinical Neurology
    • Epilepsy diagnosis: Positron emission tomography

      2012, Handbook of Clinical Neurology
      Citation Excerpt :

      However, increased binding of the delta-receptor-selective antagonist was present in mid-inferior and anterior aspects of the middle and superior temporal cortex (Madar et al., 1997). [ 18F]cyclofoxy, a mu- and kappa-receptor antagonist, showed no group asymmetry (Theodore et al., 1992a). Kappa-receptor downregulation might offset mu-receptor upregulation.

    View all citing articles on Scopus
    View full text